nonlinear iterative curve-fitting program of prism (GraphPad Software Inc)
90
Structured Review
GraphPad Software Inc
nonlinear iterative curve-fitting program of prism
Nonlinear Iterative Curve Fitting Program Of Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nonlinear+iterative+curve-fitting+program/prism+curve+fitting+software/pmc07290864-95-42-43
Average 90 stars, based on 1 article reviews
Nonlinear Iterative Curve Fitting Program Of Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nonlinear+iterative+curve-fitting+program/prism+curve+fitting+software/pmc07290864-95-42-43
Average 90 stars, based on 1 article reviews
nonlinear iterative curve-fitting program of prism - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Saturation Assay:Article Title: Salvianolic acids from antithrombotic Traditional Chinese Medicine Danshen are antagonists of human P2Y 1 and P2Y 12 receptors Article Snippet: For radioligand binding, calculation of apparent binding affinities, K i = IC 50 /(1 + [radioligand]/ K d ), was performed using the nonlinear iterative curve-fitting program of Article Title: Identification and characterization of an alternative splice variant of Mpl with a high affinity for TPO and its activation of ERK1/2 signaling. Article Snippet: The thrombopoietin receptor is a crucial element in thrombopoietin-initiated signaling pathways, which stimulates the differentiation of normal hematopoietic progenitor cells, the maturation of megakaryocytes, and the generation of platelets.. In this study, we identified a novel activating variant of thrombopoietin receptor, termed Mpl-D, in human megakaryoblastic leukemia Dami cells and demonstrated that the binding affinity of the Mpl-D receptor for thrombopoietin is enhanced.. Cell cycle analysis revealed that in the presence of thrombopoietin, most Mpl-D expressing NIH3T3 (NIH3T3/Mpl-D) cells were prevalent in G1 phase while the S and G2/M populations were less frequently observed. Incubation:Article Title: Salvianolic acids from antithrombotic Traditional Chinese Medicine Danshen are antagonists of human P2Y 1 and P2Y 12 receptors Article Snippet: For radioligand binding, calculation of apparent binding affinities, K i = IC 50 /(1 + [radioligand]/ K d ), was performed using the nonlinear iterative curve-fitting program of Article Title: Identification and characterization of an alternative splice variant of Mpl with a high affinity for TPO and its activation of ERK1/2 signaling. Article Snippet: The thrombopoietin receptor is a crucial element in thrombopoietin-initiated signaling pathways, which stimulates the differentiation of normal hematopoietic progenitor cells, the maturation of megakaryocytes, and the generation of platelets.. In this study, we identified a novel activating variant of thrombopoietin receptor, termed Mpl-D, in human megakaryoblastic leukemia Dami cells and demonstrated that the binding affinity of the Mpl-D receptor for thrombopoietin is enhanced.. Cell cycle analysis revealed that in the presence of thrombopoietin, most Mpl-D expressing NIH3T3 (NIH3T3/Mpl-D) cells were prevalent in G1 phase while the S and G2/M populations were less frequently observed. Binding Assay:Article Title: Salvianolic acids from antithrombotic Traditional Chinese Medicine Danshen are antagonists of human P2Y 1 and P2Y 12 receptors Article Snippet: For radioligand binding, calculation of apparent binding affinities, K i = IC 50 /(1 + [radioligand]/ K d ), was performed using the nonlinear iterative curve-fitting program of Article Title: Identification and characterization of an alternative splice variant of Mpl with a high affinity for TPO and its activation of ERK1/2 signaling. Article Snippet: The thrombopoietin receptor is a crucial element in thrombopoietin-initiated signaling pathways, which stimulates the differentiation of normal hematopoietic progenitor cells, the maturation of megakaryocytes, and the generation of platelets.. In this study, we identified a novel activating variant of thrombopoietin receptor, termed Mpl-D, in human megakaryoblastic leukemia Dami cells and demonstrated that the binding affinity of the Mpl-D receptor for thrombopoietin is enhanced.. Cell cycle analysis revealed that in the presence of thrombopoietin, most Mpl-D expressing NIH3T3 (NIH3T3/Mpl-D) cells were prevalent in G1 phase while the S and G2/M populations were less frequently observed. |